Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Meta Platforms (Facebook)
META
|
$859M |
| 2 |
Progressive
PGR
|
$429M |
| 3 |
Netflix
NFLX
|
$368M |
| 4 |
Danaher
DHR
|
$364M |
| 5 |
Adobe
ADBE
|
$343M |
Top Sells
| 1 |
Advanced Micro Devices
AMD
|
$710M |
| 2 |
Microsoft
MSFT
|
$619M |
| 3 |
NVIDIA
NVDA
|
$447M |
| 4 |
Eli Lilly
LLY
|
$391M |
| 5 |
AbbVie
ABBV
|
$373M |
Sector Composition
| 1 | Technology | 32.66% |
| 2 | Healthcare | 19.35% |
| 3 | Industrials | 10.04% |
| 4 | Financials | 10% |
| 5 | Consumer Discretionary | 9.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2326
Anavex Life Sciences
AVXL
$807M
| $262K | ﹤0.01% |
32,265
-25
| -0.1% | -$203 |
|
2327
Evolv Technologies
EVLV
$1.39B
| $262K | ﹤0.01% |
43,665
+26,966
| +161% | +$162K |
|
2328
Conduent
CNDT
$447M
| $259K | ﹤0.01% |
76,122
+79
| +0.1% | +$269 |
|
2329
Theravance Biopharma
TBPH
$703M
| $259K | ﹤0.01% |
24,988
-55
| -0.2% | -$569 |
|
2330
CEVA Inc
CEVA
$543M
| $258K | ﹤0.01% |
10,104
-11
| -0.1% | -$281 |
|
2331
Five Star Bancorp
FSBC
$702M
| $258K | ﹤0.01% |
+11,545
| New | +$258K |
|
|
PFC
2332
DELISTED
Premier Financial Corp. Common Stock
PFC
| $258K | ﹤0.01% |
16,094
-19
| -0.1% | -$304 |
|
2333
Titan International
TWI
$562M
| $256K | ﹤0.01% |
22,283
-28
| -0.1% | -$321 |
|
2334
Amplitude
AMPL
$1.51B
| $255K | ﹤0.01% |
23,178
+31
| +0.1% | +$341 |
|
2335
Community Trust Bancorp
CTBI
$1.06B
| $254K | ﹤0.01% |
7,155
+4
| +0.1% | +$142 |
|
2336
British American Tobacco
BTI
$122B
| $254K | ﹤0.01% |
7,657
+1,602
| +26% | +$53.2K |
|
2337
Hackett Group
HCKT
$576M
| $252K | ﹤0.01% |
11,293
-48
| -0.4% | -$1.07K |
|
2338
Titan Machinery
TITN
$482M
| $252K | ﹤0.01% |
8,547
-12
| -0.1% | -$354 |
|
|
FBMS
2339
DELISTED
The First Bancshares, Inc.
FBMS
| $252K | ﹤0.01% |
9,760
-33
| -0.3% | -$852 |
|
2340
Heritage Financial
HFWA
$842M
| $252K | ﹤0.01% |
15,544
-19
| -0.1% | -$308 |
|
2341
Editas Medicine
EDIT
$248M
| $251K | ﹤0.01% |
30,511
-37
| -0.1% | -$305 |
|
2342
Xperi
XPER
$284M
| $251K | ﹤0.01% |
19,086
-68
| -0.4% | -$894 |
|
|
MODV
2343
DELISTED
ModivCare
MODV
| $250K | ﹤0.01% |
5,525
-179,090
| -97% | -$8.09M |
|
2344
Allient
ALNT
$772M
| $249K | ﹤0.01% |
6,230
-10
| -0.2% | -$399 |
|
|
ME
2345
DELISTED
23andMe Holding Co. Class A Common Stock
ME
| $248K | ﹤0.01% |
7,113
+3,925
| +123% | +$137K |
|
2346
Trustco Bank Corp NY
TRST
$753M
| $248K | ﹤0.01% |
8,680
-11
| -0.1% | -$315 |
|
2347
REX American Resources
REX
$1.02B
| $248K | ﹤0.01% |
7,135
-9
| -0.1% | -$313 |
|
2348
York Water
YORW
$447M
| $248K | ﹤0.01% |
6,014
-8
| -0.1% | -$330 |
|
2349
Health Catalyst
HCAT
$238M
| $248K | ﹤0.01% |
19,808
-25
| -0.1% | -$313 |
|
|
FPI
2350
Farmland Partners
FPI
$473M
| $248K | ﹤0.01% |
20,286
-43
| -0.2% | -$525 |
|